Bioventus Inc. BVS
Bioventus Inc. statistics & valuation
Market cap$817.0M
P / E35.9×
P / S1.4×
P / B3.6×
P / FCF11.3×
Net margin4.0%
Return on equity10.0%
FCF margin12.7%
Net debt$227.7M
Net debt / EBITDA2.3×
Enterprise value USD$1.0B
EV / EBITDA10.3×
Earnings yield EBIT/EV5.2%
Return on capital10.3%
Graham number -64.3%$4.96
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($4.96); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Gross margin | 68.3% | 67.7% | 64.1% | 64.6% | 70.3% | 72.7% |
| Operating margin | 9.5% | -2.7% | -16.0% | -32.7% | 2.8% | 6.6% |
| Net margin | 4.0% | -6.3% | -30.5% | -31.0% | 4.5% | 5.1% |
| FCF margin | 12.7% | 6.6% | 2.0% | -2.9% | 2.2% | 17.3% |
| Return on assets | 3.3% | -5.0% | -19.3% | -11.6% | 1.6% | 3.3% |
| Return on equity | 10.0% | -19.5% | -70.7% | -38.5% | 3.2% | — |
| Debt / equity | 1.22× | 1.66× | 1.66× | 0.93× | 0.59× | — |
| Current ratio | 1.70 | 1.31 | 1.53 | 0.90 | 1.45 | 1.73 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.